Structural study for substrate recognition of human N‐terminal glutamine amidohydrolase 1 in the arginine N‐degron pathway

Author:

Kang Jin Mo1ORCID,Park Joon Sung1,Lee Jae Seok1,Jang Jun Young1,Han Byung Woo1ORCID

Affiliation:

1. Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy Seoul National University Seoul Republic of Korea

Abstract

AbstractThe N‐degron pathway determines the half‐life of proteins by selectively destabilizing the proteins bearing N‐degrons. N‐terminal glutamine amidohydrolase 1 (NTAQ1) plays an essential role in the arginine N‐degron (Arg/N‐degron) pathway as an initializing enzyme via the deamidation of the N‐terminal (Nt) glutamine (Gln). However, the Nt‐serine‐bound conformation of hNTAQ1 according to the previously identified crystal structure suggests the possibility of other factors influencing the recognition of Nt residues by hNTAQ1. Hence, in the current study, we aimed to further elucidate the substrate recognition of hNTAQ1; specifically, we explored 12 different substrate‐binding conformations of hNTAQ1 depending on the subsequent residue of Nt‐Gln. Results revealed that hNTAQ1 primarily interacts with the protein Nt backbone, instead of the side chain, for substrate recognition. Here, we report that the Nt backbone of proteins appears to be a key component of hNTAQ1 function and is the main determinant of substrate recognition. Moreover, not all second residues from Nt‐Gln, but rather distinctive and charged residues, appeared to aid in detecting substrate recognition. These new findings define the substrate‐recognition process of hNTAQ1 and emphasize the importance of the subsequent Gln residue in the Nt‐Gln degradation system. Our extensive structural and biochemical analyses provide insights into the substrate specificity of the N‐degron pathway and shed light on the mechanism underlying hNTAQ1 substrate recognition. An improved understanding of the protein degradation machinery could aid in developing therapies to promote overall health through enhanced protein regulation, such as targeted protein therapies.

Funder

National Research Foundation of Korea

Korea Health Industry Development Institute

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3